LIPELLA PHARMACEUTICALS INC (LIPO) Forecast, Price Target & Analyst Ratings

NASDAQ:LIPO • US53630L2097

Current stock price

2.36 USD
-0.35 (-12.75%)
At close:
1.8001 USD
-0.56 (-23.72%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LIPELLA PHARMACEUTICALS INC (LIPO).

Forecast Snapshot

Consensus Price Target

Price Target
$10.20
+ 332.20% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.20
Upside
+ 332.20%
From current price of $2.36 to mean target of $10.20, Based on 7 analyst forecasts
Low
$10.10
Median
$10.20
High
$10.50

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for LIPO. The average price target is 10.2 USD. This implies a price increase of 332.2% is expected in the next year compared to the current price of 2.36.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LIPO Current Analyst RatingLIPO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

LIPO Historical Analyst RatingsLIPO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
LIPO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LIPO.
In the previous month the buy percentage consensus was at a similar level.
LIPO was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-04-09Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
LIPO revenue by date.LIPO revenue by date.
184.2K
-28.99%		449.6K
144.08%		536.4K
19.31%
-100.00%		N/A
EBITDA
YoY % growth
LIPO ebitda by date.LIPO ebitda by date.
N/A-4.744M-5.078M
-7.03%		N/AN/AN/A
EBIT
YoY % growth
LIPO ebit by date.LIPO ebit by date.
-2.59M
-35.18%		-4.746M
-83.26%		-5.081M
-7.05%		-8.556M
-68.40%		-12.834M
-50.00%		-14.826M
-15.52%
Operating Margin
LIPO operating margin by date.LIPO operating margin by date.
-1,405.92%-1,055.60%-947.15%N/AN/AN/A
EPS
YoY % growth
LIPO eps by date.LIPO eps by date.
N/AN/AN/A-5.30
33.76%		-17.77
-235.00%		-2.22
87.49%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LIPO Yearly Revenue VS EstimatesLIPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
LIPO Yearly EPS VS EstimatesLIPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
19.87%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LIPELLA PHARMACEUTICALS INC / LIPO Forecast FAQ

Can you provide the average price target for LIPELLA PHARMACEUTICALS INC stock?

7 analysts have analysed LIPO and the average price target is 10.2 USD. This implies a price increase of 332.2% is expected in the next year compared to the current price of 2.36.

Can you provide the consensus rating for LIPELLA PHARMACEUTICALS INC stock?

The consensus rating for LIPELLA PHARMACEUTICALS INC (LIPO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.